Growth Metrics

LifeMD (LFMD) Cash & Current Investments (2016 - 2025)

LifeMD's Cash & Current Investments history spans 14 years, with the latest figure at $37.1 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 13.5% year-over-year to $37.1 million; the TTM value through Dec 2025 reached $37.1 million, up 13.5%, while the annual FY2025 figure was $37.1 million, 13.5% up from the prior year.
  • Cash & Current Investments reached $37.1 million in Q4 2025 per LFMD's latest filing, up from $24.2 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $41.5 million in Q4 2021 to a low of $4.1 million in Q4 2022.
  • Average Cash & Current Investments over 5 years is $24.0 million, with a median of $24.9 million recorded in 2022.
  • Peak YoY movement for Cash & Current Investments: surged 5494.51% in 2021, then tumbled 90.16% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $41.5 million in 2021, then crashed by 90.16% to $4.1 million in 2022, then surged by 723.13% to $33.6 million in 2023, then dropped by 2.79% to $32.7 million in 2024, then grew by 13.5% to $37.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Cash & Current Investments are $37.1 million (Q4 2025), $24.2 million (Q3 2025), and $36.5 million (Q2 2025).